Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain Y-linked 19 pseudogene (CDY19P) is a non-coding genetic element classified as a pseudogene derived from the chromodomain Y-linked gene family. Unlike its protein-coding relatives, this pseudogene does not produce a functional protein and does not have an established biological function, disease association, or pharmacological relevance. CDY family genes generally participate in chromatin remodeling and spermatogenesis, but pseudogenes such as CDY19P are considered non-functional, and no therapeutic, diagnostic, or mechanistic data are available for this locus[2][5]. Key context: - Pseudogenes like CDY19P arise from gene duplication or retrotransposition but have lost their coding potential through mutation, and are generally not transcribed or translated into functional proteins[2][5]. - CDY family genes and related chromodomain-containing proteins are involved in chromatin remodeling, gene regulation, and spermatogenesis, but CDY19P plays no active role in these biological processes[5]. For structured or clinical/therapeutic databases, CDY19P should be flagged as a non-target, non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain Y-linked 19 pseudogene (CDY19P).